Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$1.31
+0.00%
Mkt Cap $152.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $1.34M | $1.37M | +2.42% | -$0.27 | -$0.27 | +0.00% | — | — |
| Q4 2025 Nov 13, 2025 | $1.20M | $1.74M | +45.31% | -$0.29 | -$0.27 | +6.90% | — | — |
| Q3 2025 Aug 12, 2025 | $1.15M | $1.91M | +65.98% | -$0.35 | -$0.29 | +17.14% | — | — |
| Q2 2025 May 13, 2025 | $1.18M | $1.63M | +37.53% | -$0.39 | -$0.32 | +17.95% | — | — |
| Q1 2025 Mar 5, 2025 | $1.57M | $1.86M | +18.57% | -$0.44 | -$0.31 | +29.55% | — | — |
| Q4 2024 Nov 12, 2024 | $1.32M | $3.07M | +132.88% | -$0.42 | -$0.40 | +4.76% | — | — |
| Q3 2024 Aug 13, 2024 | $1.41M | $6.77M | +380.28% | -$0.47 | -$0.33 | +29.79% | — | — |
| Q2 2024 May 9, 2024 | $1.11M | $1.93M | +73.42% | -$0.47 | -$0.47 | +0.00% | — | — |
| Q1 2024 Feb 26, 2024 | $1.59M | $1.68M | +5.41% | -$0.57 | -$0.45 | +21.05% | — | — |
| Q4 2023 Nov 8, 2023 | $1.64M | $1.94M | +18.54% | -$0.59 | -$0.46 | +22.03% | — | — |
| Q3 2023 Aug 8, 2023 | $5.53M | $933.00K | -83.13% | -$0.58 | -$0.54 | +6.90% | — | — |
| Q2 2023 May 3, 2023 | $35.50M | $58.98M | +66.14% | -$0.55 | -$0.19 | +65.45% | — | — |
| Q1 2023 Feb 28, 2023 | $17.88M | $44.36M | +148.07% | -$0.86 | -$0.58 | +32.56% | — | — |
| Q4 2022 Nov 3, 2022 | $15.28M | $14.98M | -1.96% | -$0.93 | -$0.86 | +7.53% | — | — |
| Q3 2022 Aug 3, 2022 | $12.54M | $18.55M | +47.95% | -$0.86 | -$0.79 | +8.14% | — | — |
| Q2 2022 May 4, 2022 | $9.01M | $18.41M | +104.34% | -$0.78 | -$0.68 | +12.82% | — | — |
| Q1 2022 Feb 28, 2022 | $11.31M | $17.07M | +50.91% | -$0.68 | -$0.72 | -5.88% | — | — |
| Q4 2021 Nov 4, 2021 | $7.89M | $14.22M | +80.29% | -$0.58 | -$0.57 | +1.72% | — | — |
| Q3 2021 Aug 4, 2021 | $13.41M | $13.41M | +0.00% | -$0.52 | -$0.58 | -11.54% | — | — |
| Q2 2021 May 5, 2021 | $9.85M | $11.14M | +13.16% | -$0.42 | -$0.48 | -14.29% | — | — |